Will active surveillance for clinically localized prostate cancer survive in the era of individualized medicine?

Giorgio Gandaglia1, Gianluca Giannarini2, Nazareno Suardi1

  • 1Division of Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.

European Urology
|May 20, 2014
PubMed